Crossmark Global Holdings’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.5M Buy
65,193
+2,087
+3% +$434K 0.2% 112
2026
Q1
$13.3M Buy
63,106
+1,055
+2% +$227K 0.2% 121
2025
Q4
$12.8M Buy
62,051
+2,095
+3% +$394K 0.18% 129
2025
Q3
$9.41M Buy
59,956
+3,434
+6% +$530K 0.14% 171
2025
Q2
$9.5M Sell
56,522
-2,943
-5% -$437K 0.15% 160
2025
Q1
$8.19M Sell
59,465
-13,122
-18% -$1.67M 0.14% 173
2024
Q4
$8.59M Sell
72,587
-1,405
-2% -$164K 0.16% 157
2024
Q3
$8.18M Sell
73,992
-676
-0.9% -$70.7K 0.15% 172
2024
Q2
$7.34M Buy
74,668
+8,786
+13% +$895K 0.14% 168
2024
Q1
$7.37M Sell
65,882
-1,459
-2% -$157K 0.14% 171
2023
Q4
$6.79M Sell
67,341
-136,886
-67% -$13.6M 0.14% 173
2023
Q3
$18.7M Buy
204,227
+137,175
+205% +$12.4M 0.42% 45
2023
Q2
$6.15M Sell
67,052
-4,726
-7% -$399K 0.13% 188
2023
Q1
$5.42M Sell
71,778
-732
-1% -$55.2K 0.13% 196
2022
Q4
$5.57M Buy
72,510
+7,208
+11% +$548K 0.14% 188
2022
Q3
$4.35M Sell
65,302
-712
-1% -$45.1K 0.12% 201
2022
Q2
$3.45M Sell
66,014
-184,970
-74% -$10.5M 0.09% 254
2022
Q1
$14.2M Buy
250,984
+14,729
+6% +$789K 0.32% 71
2021
Q4
$12.2M Sell
236,255
-6,000
-2% -$294K 0.26% 97
2021
Q3
$12M Buy
242,255
+9,755
+4% +$529K 0.28% 92
2021
Q2
$13.3M Buy
232,500
+202,821
+683% +$11.9M 0.31% 75
2021
Q1
$1.8M Sell
29,679
-1,312
-4% -$72.4K 0.04% 401
2020
Q4
$1.66M Buy
30,991
+6,102
+25% +$317K 0.04% 418
2020
Q3
$1.17M Sell
24,889
-620
-2% -$31.8K 0.03% 490
2020
Q2
$1.33M Buy
25,509
+1,779
+7% +$91.7K 0.04% 444
2020
Q1
$1.14M Buy
23,730
+235
+1% +$12.2K 0.04% 428
2019
Q4
$1.19M Sell
23,495
-19,870
-46% -$1.03M 0.03% 511
2019
Q3
$2.05M Sell
43,365
-1,327
-3% -$60.6K 0.06% 349
2019
Q2
$2.1M Buy
44,692
+1,519
+4% +$70.1K 0.06% 373
2019
Q1
$2.08M Buy
43,173
+235
+0.5% +$11.8K 0.06% 365
2018
Q4
$1.92M Sell
42,938
-1,373
-3% -$71.6K 0.06% 366
2018
Q3
$2.39M Buy
44,311
+458
+1% +$23.4K 0.06% 358
2018
Q2
$2.14M Sell
43,853
-1,190
-3% -$67.5K 0.06% 371
2018
Q1
$2.82M Sell
45,043
-6,511
-13% -$447K 0.07% 322
2017
Q4
$3.16M Buy
51,554
+6,696
+15% +$414K 0.08% 314
2017
Q3
$3M Buy
+44,858
New +$3.17M 0.08% 308
2016
Q3
$3M Buy
+44,858
New +$3.63M 0.08% 308

Other funds holding CAH

Crossmark Global Holdings's CAH Position: Q2 2026 in Review

Crossmark Global Holdings increased its Cardinal Health (CAH) stake by 3.3% in Q2 2026, buying an estimated $434K and bringing the position to 65,193 shares worth $15.5M. The position accounts for 0.2% of the portfolio, ranked #112.

Crossmark Global Holdings first reported a position in CAH in Q3 2016 and has held it in 37 quarters since. The position peaked at $18.7M in Q3 2023. 218 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Crossmark Global Holdings held 65,193 shares of Cardinal Health worth $15.5M as of Q2 2026.
  • Crossmark Global Holdings bought 2,087 Cardinal Health shares in Q2 2026, an estimated $434K.
  • Cardinal Health made up 0.2% of Crossmark Global Holdings's portfolio in Q2 2026, its #112 holding.
  • Crossmark Global Holdings first reported a position in Cardinal Health in Q3 2016 and has held it in 37 quarters since.
  • Crossmark Global Holdings's Cardinal Health position peaked at $18.7M in Q3 2023.
  • 218 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.